Lenacapavir new antiretroviral drug for multi drug resistant HIV infection approved by USFDA
New anti-retroviral drug Lenacapavir approved by USFDA for treatment of multi drug resistant HIV 1 infection. On 22-Dec-2022 United States…
New anti-retroviral drug Lenacapavir approved by USFDA for treatment of multi drug resistant HIV 1 infection. On 22-Dec-2022 United States…